Skip to main content
Clinical Trials/NCT02511925
NCT02511925
Completed
Not Applicable

A Pragmatic Crossover Cluster Randomised Study of Electronic Compliance Monitoring of Staff Hand Sanitisation in Critical Care (HANDS Study)

Royal Brompton & Harefield NHS Foundation Trust1 site in 1 country1,065 target enrollmentNovember 2013
ConditionsCross Infection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cross Infection
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Enrollment
1065
Locations
1
Primary Endpoint
Composite health care infection rate
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

If patients acquire a new infection whilst in hospital this can cause significant morbidity, prolonged hospitalisation and even death. Indeed, there is much public concern about infections such as MRSA. Patients who require intensive care are probably at the greatest risk.

Appropriate hand hygiene by healthcare workers can reduce infection rates and is a key goal of many patient safety initiatives. Worldwide, hand hygiene compliance has been estimated at only 38.7% despite the intervention being simple and cheap. Reasons for poor compliance include lack of time, skin irritation, lack of facilities, intensity of workload and forgetfulness. Furthermore, since cross infection may not be apparent for some days, staff may not associate their (lack of) actions with having caused harm.

Measuring compliance levels enables staff to understand whether they could improve. Direct observation of staff is labour intensive and is not continuous or universal. We will monitor hand hygiene compliance with a newly developed electronic system (MedSense, General Sensing Inc.). We will use the data to provide feedback to the staff in several ways. We hypothesise that comprehensive personalised feedback will reduce healthcare associated infections. We will undertake the study in three intensive care units.

Detailed Description

All patients admitted to three intensive care units will be monitored for healthcare associated infections. In parallel the units will be cluster randomised to implement the electronic compliance monitoring in three different ways: * Unit level feed back every week of current compliance for each of three staff groupings (doctors, nurses, allied health professionals) * Personalised feedback in the form of an email at the end of a shift stating an individuals performance relative to the average for their professional grouping. * Real time feedback in the form of a badge worn by the healthcare worker that vibrates when the system thinks they have missed or are about to miss an opportunity for hand hygiene. All healthcare workers will receive the level of feedback defined in the randomisation for the duration of the three intervention periods. The units will cross-over with an interventing two week wash out period. All personal feedback will be confidential and private to the individual.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
July 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients admitted to the intensive care units
  • All healthcare workers caring for the patients on the intensive care units.

Exclusion Criteria

  • Healthcare workers with skin sensitivity to both alcohol hand rub and soap

Outcomes

Primary Outcomes

Composite health care infection rate

Time Frame: Until the end of the second calendar day following ICU discharge

One of the following three: Bacteriological proven infection at a normally sterile site. The sterile sites vein considered are a prior defined as blood, broncho-alveolar lavage, urine sampled from a catheter, chest drain fluid, and surgical wounds. Blood cultures that grow normal skin commensals will be included Endotracheal secretions that culture organisms other than normal upper respiratory tract flora Clostridium difficult related diarrhoea

Secondary Outcomes

  • Adverse event rate(24 weeks)
  • Incidence of catheter associated urinary tract infections(Until the end of the second calendar day following ICU discharge)
  • Incidence of ventilator associated pneumonia(Until the end of the second calendar day following ICU discharge)
  • Incidence of surgical site infection(Until the end of the second calendar day following ICU discharge)
  • Incidence of central line associated blood stream infections(Until the end of the second calendar day following ICU discharge)
  • Incidence of clostridium difficult diarrhoea(Until the end of the second calendar day following ICU discharge)
  • Incidence of acquisition of new methicilllin resistant staphylococcus aureus(Until the end of the second calendar day following ICU discharge)
  • Incidence of secondary blood stream infections(Until the end of the second calendar day following ICU discharge)
  • Incidence of antibiotic resistance infections(Until the end of the second calendar day following ICU discharge)

Study Sites (1)

Loading locations...

Similar Trials